# Japanese Encephalitis Vaccine

## Imojev inj 0.5mL/dose (Private)

##### 

| TAH Drug Code      | IIMO                                                                                                                                                                                                                                                                                           |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Active immunisation against encephalitis due to Japanese encephalitis virus                                                                                                                                                                                                                    |
| Dosing             | IM, 0.5mL, Age > or = 9 months - < 18 years: primary immunization.A booster dose after 12-24 months. Age > or = 18 years: a single dose.                                                                                                                                                       |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                  |
| Contraindications  | Avoid use in the following unless absolutely necessary: patients with fever or severe malnutrition; CV, renal or hepatic diseases in acute, exacerbating or active phases; history of abnormal adverse reactions caused by this vaccine; history of spasmodic symptoms within 1 yr; pregnancy. |
| Adverse Effects    | Local reactions eg redness, swelling, tenderness or systemic reactions eg fever, chill, headache, lassitude. Rarely, severe adverse reactions manifesting as generalized urticaria or angioedema may occur.                                                                                    |
| Pregnancy          | No Data                                                                                                                                                                                                                                                                                        |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                |

## Imojev (減毒日腦，Government) 0.5mL/dose

##### 

| TAH Drug Code      | IJEV0                                                                                                                                                                                                                                                                                          |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Active immunisation against encephalitis due to Japanese encephalitis virus                                                                                                                                                                                                                    |
| Dosing             | IM, 0.5mL, Age > or = 9 months - < 18 years: primary immunization.A booster dose after 12-24 months. Age > or = 18 years: a single dose.                                                                                                                                                       |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                  |
| Contraindications  | Avoid use in the following unless absolutely necessary: patients with fever or severe malnutrition; CV, renal or hepatic diseases in acute, exacerbating or active phases; history of abnormal adverse reactions caused by this vaccine; history of spasmodic symptoms within 1 yr; pregnancy. |
| Adverse Effects    | Local reactions eg redness, swelling, tenderness or systemic reactions eg fever, chill, headache, lassitude. Rarely, severe adverse reactions manifesting as generalized urticaria or angioedema may occur.                                                                                    |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                        |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                        |

